| Oct 21 |
BioVie Inc. Announces Pricing of Registered Direct Offering and Concurrent Private Placement Priced At-the-Market Under Nasdaq Rules
|
| Oct 15 |
BioVie Receives Notice of Allowance for Japan Patent Application Covering Novel Liquid Formulation of Terlipressin
|
| Oct 11 |
BioVie and Genetic Technologies Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
|
| Oct 1 |
BioVie Receives Notice of Allowance for United States Patent Application Covering Novel Liquid Formulation of Terlipressin
|
| Sep 25 |
BioVie Inc. Announces Closing of Public Offering
|
| Sep 24 |
Why Maison Solutions Shares Are Trading Higher By Around 91%; Here Are 20 Stocks Moving Premarket
|
| Sep 24 |
BioVie plummets 50%, prices $3M stock offering
|
| Sep 24 |
BioVie Inc. Announces Pricing of Public Offering
|
| Sep 23 |
BioVie Inc. Announces Proposed Public Offering
|
| Sep 16 |
BioVie Secures All Scientific Approvals Needed to Receive Additional $12.6 Million of Grant Funding to Launch Planned Phase 2 Trial to Evaluate Bezisterim in Long COVID
|
